Correction to : Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients
| Errataetall: |
ErratumFor: Clin Exp Nephrol. 2022 Jun;26(6):571-580. - PMID 35133533 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Clinical and experimental nephrology - 26(2022), 6 vom: 09. Juni, Seite 581-582 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Toda, Masataro [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 18.05.2022 published: Print ErratumFor: Clin Exp Nephrol. 2022 Jun;26(6):571-580. - PMID 35133533 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1007/s10157-022-02203-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM337937273 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM337937273 | ||
| 003 | DE-627 | ||
| 005 | 20231225235539.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10157-022-02203-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1126.xml |
| 035 | |a (DE-627)NLM337937273 | ||
| 035 | |a (NLM)35262832 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Toda, Masataro |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction to |b Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 18.05.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a ErratumFor: Clin Exp Nephrol. 2022 Jun;26(6):571-580. - PMID 35133533 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Yoshifuji, Ayumi |e verfasserin |4 aut | |
| 700 | 1 | |a Kikuchi, Kan |e verfasserin |4 aut | |
| 700 | 1 | |a Koinuma, Masayoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Komatsu, Motoaki |e verfasserin |4 aut | |
| 700 | 1 | |a Fujii, Kentaro |e verfasserin |4 aut | |
| 700 | 1 | |a Kato, Ai |e verfasserin |4 aut | |
| 700 | 1 | |a Kikuchi, Takahide |e verfasserin |4 aut | |
| 700 | 1 | |a Nakazawa, Atsushi |e verfasserin |4 aut | |
| 700 | 1 | |a Ryuzaki, Munekazu |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical and experimental nephrology |d 1998 |g 26(2022), 6 vom: 09. Juni, Seite 581-582 |w (DE-627)NLM096492473 |x 1437-7799 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2022 |g number:6 |g day:09 |g month:06 |g pages:581-582 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10157-022-02203-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2022 |e 6 |b 09 |c 06 |h 581-582 | ||